Insights and lessons learned from a prospective clinical pharmacology study in allogeneic hematopoietic stem cell transplant during the COVID‐19 pandemic

• Jing Zhu,
• Gauri Rao,
• Paul M. Armistead,
• Jonathan Ptachcinski,
• Daniel L. Weiner,
• Tim Wiltshire,
• Daniel J. Crona

Affiliations

Jing Zhu

Division of Pharmacotherapy and Experimental Therapeutics University of North Carolina Eshelman School of Pharmacy Chapel Hill North Carolina USA

Gauri Rao

Division of Pharmacotherapy and Experimental Therapeutics University of North Carolina Eshelman School of Pharmacy Chapel Hill North Carolina USA

Paul M. Armistead

Division of Hematology, Department of Medicine University of North Carolina School of Medicine Chapel Hill North Carolina USA

Jonathan Ptachcinski

Department of Pharmacy University of North Carolina Hospitals and Clinics Chapel Hill North Carolina USA

Daniel L. Weiner

Division of Pharmacotherapy and Experimental Therapeutics University of North Carolina Eshelman School of Pharmacy Chapel Hill North Carolina USA

Tim Wiltshire

Division of Pharmacotherapy and Experimental Therapeutics University of North Carolina Eshelman School of Pharmacy Chapel Hill North Carolina USA

Daniel J. Crona

Division of Pharmacotherapy and Experimental Therapeutics University of North Carolina Eshelman School of Pharmacy Chapel Hill North Carolina USA